UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) P/E ratio
As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a P/E ratio of 30.1×. Over the past ten years it has ranged from 11.7× (March 2020) to 55.3× (September 2024); the current reading is higher than 80% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 25.0× | (21.27%) |
| FY2024 | 31.8× | 12.92% |
| FY2023 | 28.2× | 34.48% |
| FY2022 | 20.9× | (37.12%) |
| FY2021 | 33.3× | 27.91% |
| FY2020 | 26.0× | 39.59% |
| FY2019 | 18.7× | 20.45% |
| FY2018 | 15.5× | (29.18%) |
| FY2017 | 21.9× | (5.75%) |
| FY2016 | 23.2× | 4.21% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 30.0× | 5.83% |
| Jun 2026 | 28.3× | 30.22% |
| Mar 2026 | 21.8× | (13.10%) |
| Dec 2025 | 25.0× | 9.36% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ALMR Alamar Biosciences, Inc. compare | n/m |
| TMDX TransMedics Group, Inc. compare | 16.4× |
| INSP Inspire Medical Systems, Inc. compare | 19.1× |
| UFPT UFP Technologies, Inc. | 30.1× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement